SBI Okasan Asset Management Co.Ltd. purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,547 shares of the semiconductor company's stock, valued at approximately $1,699,000.
Several other hedge funds and other institutional investors have also made changes to their positions in SNPS. Brighton Jones LLC lifted its position in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in shares of Synopsys by 11.6% in the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock valued at $326,000 after acquiring an additional 79 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock valued at $1,291,000 after acquiring an additional 395 shares in the last quarter. WINTON GROUP Ltd lifted its position in shares of Synopsys by 9.2% in the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock valued at $389,000 after acquiring an additional 64 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in shares of Synopsys by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company's stock valued at $36,962,000 after acquiring an additional 1,505 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. KeyCorp restated an "overweight" rating on shares of Synopsys in a research report on Thursday. Morgan Stanley raised their target price on Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a research report on Thursday. Stifel Nicolaus raised their target price on Synopsys from $550.00 to $600.00 and gave the company a "buy" rating in a research report on Thursday. Wells Fargo & Company increased their price target on Synopsys from $505.00 to $535.00 and gave the company an "equal weight" rating in a report on Thursday. Finally, Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $563.81.
View Our Latest Research Report on SNPS
Synopsys Price Performance
NASDAQ:SNPS opened at $480.64 on Friday. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The stock has a market cap of $92.07 billion, a PE ratio of 111.26, a P/E/G ratio of 4.31 and a beta of 1.25. The stock has a 50 day moving average price of $458.59 and a 200 day moving average price of $454.30.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.91% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same quarter last year, the firm earned $3.67 earnings per share. The business's revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.28 EPS for the current fiscal year.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys reported fiscal Q2 results above expectations, with revenue of $2.276 billion and non-GAAP EPS of $3.35, both topping estimates. The company also raised full-year revenue and EPS guidance, signaling continued demand for AI chip-design software and related tools. Synopsys Posts Financial Results for Second Quarter Fiscal Year 2026
- Positive Sentiment: Management said AI-related demand remains strong, and the company highlighted expanding benefits from the Ansys deal and operating-margin improvement, which could support longer-term growth. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: Synopsys reached a cooperation agreement with Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which may increase pressure for operational improvements and shareholder-friendly changes. Synopsys reaches settlement with Elliott, says Jesse Cohn to join board
- Neutral Sentiment: Several analysts responded positively by lifting price targets, but at least one firm still has an underperform/neutral view, showing that Wall Street is still split on the stock’s upside from current levels. Analyst target updates
- Neutral Sentiment: Commentary around the stock emphasizes valuation concerns after a strong run, suggesting some investors may be pausing to reassess how much of the AI growth story is already priced in. Is It Too Late To Consider Synopsys (SNPS) After Recent Valuation Concerns?
- Negative Sentiment: The shares fell despite the beat-and-raise report, indicating investors are worried about execution risk, integration complexity, and weakness in parts of the chip-IP business. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.